About Us

Prostate cancer

Urothelial cancer


Functional Urology


Pediatric urology


Research Objectives

We investigate clinical, epidemiological, pathological, molecular and genetic characteristics of urological diseases. Our goal is to improve urological healthcare, from the general practitioner to tertiary academic care.


The Department of Urology of the Erasmus University Medical Center, Rotterdam, is embedded in the dynamic, internationally competitive research community of  several clinical, translational and basic research groups. Our focus lies in Protate Cancer, Urothelial Cancer, Functional Urology, Andrology and Pediatric Urology. We have longstandig collaborations with multiple other acadamic centers, both internationally and at a national level, and host fruitful relationships with our industry partners. Our department is renowed for participation at the highest level to improve European Patient Guidelines.

Academic Excellence

Our motto: “research” = care. We aim to improve the diagnosis, treatment and outcome in patients with urologic diseases by translational, clinical and epidemiological research, and education of students and professionals. Providing excellent academic care at a tertiary level is in our DNA. Do you want to be part of our team, either as as aspiring researcher or student, don’t hesitate to send your contact information to one of our Principal Investigators.

The Department of Urology is placed in the Staff Tower (Na buidling), the Erasmus MC Cancer Institute (Be building) and in the research tower (Ee building). The Department Chair is Dr. Joost L. Boormans.

Upcoming Events

Latest news

New publication: Variation of diagnosis and treatment of catheter-associated urinary tract infections: an online survey among caretakers involved

Abstract Tess van Doorn 1, Sophie A Berendsen 2, Rosa L Coolen 2, Jeroen R Scheepe 2, Bertil F M Blok 2 Background: The diagnosis of a clinically significant...
Read More

New publication: Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U

Abstract Hendrik Van Poppel 1, Monique J Roobol 2, Arunah Chandran 3 Background: The European Association of Urology, together with consortium partners, has launched PRAISE-U...
Read More

New publication: From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life

Abstract Renée Hogenhout 1, Sebastiaan Remmers 2, Marlies E van Slooten-Midderigh 2, Ivo I de Vos 2, Monique J Roobol 2; ERSPC Rotterdam Study Group 2 Background: Previous research quantified the effect...
Read More

New publication: The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates

 Abstract Background: Currently, transperineal prostate biopsy (TPB) is preferred over transrectal biopsy (TRB) because of less infectious complications and improved clinically...
Read More

New publication: Long-term beneficial effects of mirabegron in pediatric patients with therapy-refractory neurogenic lower urinary tract dysfunction

 Abstract Introduction: Neurogenic lower urinary tract dysfunction (NLUTD) in children can cause renal failure and urinary incontinence if not treated sufficiently....
Read More

New publication: Performance of MRI-based Prostate Cancer Risk Calculators and decision strategies in two large European medical centres

 Abstract Objectives: To compare the performance of currently available biopsy decision support tools incorporating magnetic resonance imaging (MRI) findings in predicting...
Read More

New publication: The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office

 Abstract Context: Haematuria can be macroscopic (visible haematuria [VH]) or microscopic (nonvisible haematuria [NVH]), and may be caused by a number...
Read More

New publication: Effect duration of the initial course of peroneal electrical Transcutaneous NeuroModulation in patients with overactive bladder

 Abstract Purpose: The aim of this prospective 12-month follow-up study is to evaluate the persistence of the treatment effect achieved...
Read More

New publication: Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids

 Abstract Tumor organoids have been pushed forward as advanced model systems for in vitro oncology drug testing, with the eventual...
Read More

New publication: The CHASIT study: sequential chemo-immunotherapy in patients with locally advanced urothelial cancer – a non-randomized phase II clinical trial

Abstract Background: Patients with locally advanced irresectable or clinically node positive urothelial cancer (UC) have a poor outcome. Currently, these patients...
Read More

New publication: Site-specific analysis of ribosomal 2’O-methylation by quantitative reverse transcription PCR under low deoxynucleotide triphosphate concentrations

 Abstract Ribose 2'O-methylation (Nm, ribomethylation) is the most abundant RNA modification present in rRNA. It has been shown that alterations...
Read More

Interview: ‘Prostate consultation lowers overdiagnosis prostate cancer’

Renée Hogenhout, M.D. was interviewed by DOQ-arts aan het woord about her promising findings on a new prostate consultation in...
Read More

New publication: Impact of comedonecrosis on prostate cancer outcome: a systematic review

Kaveri T S Aiyer 1, Lisa J Kroon 1, Geert J L H van Leenders 1 Abstract Cribriform architecture has been recognised as an independent...
Read More

New publication: The Europa Uomo Patient Reported Outcome Study 2.0-Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making

Lionne D F Venderbos 1, Sebastiaan Remmers 2, André Deschamps 3, John Dowling 3, Ernst-Günter Carl 3, Nuno Pereira-Azevedo 4, Monique J Roobol 2 Abstract Background: To further strengthen the voice of patients, Europa...
Read More

Interview Amazing ErasmusMC NMIBC

Christiaan de Jong and Tahlita Zuiverloon were interviewed by Amazing ErasmusMC on their recently published study on non-muscle-invasive bladder cancer...
Read More

New publication: Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin

Florus C de Jong 1, Teemu D Laajala 2 3, Robert F Hoedemaeker 4, Kimberley R Jordan 5, Angelique C J van der Made 6, Egbert R Boevé 7, Deric K E van...
Read More

New publication: Differences between brain responses to peroneal electrical transcutaneous neuromodulation and transcutaneous tibial nerve stimulation, two treatments for overactive bladder

Jan Krhut 1 2, Jaroslav Tintěra 3, Michal Rejchrt 4, Barbora Skugarevská 1 2, Roman Zachoval 5, Peter Zvara 6 7, Bertil F M Blok 8   Abstract Objectives: To compare brain responses to peroneal electrical transcutaneous...
Read More

New publication: Shifting risk-stratified early prostate cancer detection to a primary healthcare setting

Renée Hogenhout 1, Daniël F Osses 1, Arnout R Alberts 1, Hanne G Buizer-Rijksen 2, Sebastiaan Remmers 1, Monique J Roobol 1 Abstract Objective: To evaluate the feasibility of multivariable risk stratification...
Read More

New publication: Active Surveillance for Prostate Cancer: Past, Current, and Future Trends

Ivo I de Vos 1, Henk B Luiting 1, Monique J Roobol 1 Abstract In response to the rising incidence of indolent, low-risk prostate cancer...
Read More

New publication: A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines

Joep J de Jong 1, Olga M Pijpers 2, Kim E M van Kessel 2, Joost L Boormans 2, Wim Van Criekinge 3, Ellen C Zwarthoff 4, Yair Lotan 5 Abstract Background: According...
Read More


The full archive can be found by clicking here